192 research outputs found
Midbody and primary cilium of neural progenitors release extracellular membrane particles enriched in the stem cell marker prominin-1
Expansion of the neocortex requires symmetric divisions of neuroepithelial cells, the primary progenitor cells of the developing mammalian central nervous system. Symmetrically dividing neuroepithelial cells are known to form a midbody at their apical (rather than lateral) surface. We show that apical midbodies of neuroepithelial cells concentrate prominin-1 (CD133), a somatic stem cell marker and defining constituent of a specific plasma membrane microdomain. Moreover, these apical midbodies are released, as a whole or in part, into the extracellular space, yielding the prominin-1âenriched membrane particles found in the neural tube fluid. The primary cilium of neuroepithelial cells also concentrates prominin-1 and appears to be a second source of the prominin-1âbearing extracellular membrane particles. Our data reveal novel origins of extracellular membrane traffic that enable neural stem and progenitor cells to avoid the asymmetric inheritance of the midbody observed for other cells and, by releasing a stem cell membrane microdomain, to potentially influence the balance of their proliferation versus differentiation
The warm interstellar medium around the Cygnus Loop
Observations of the oxygen lines [OII]3729 and [OIII]5007 in the medium
immediately beyond the Cygnus Loop supernova remnant were carried out with the
scanning Fabry-P\'erot spectrophotometer ESOP. Both lines were detected in
three different directions - east, northeast and southwest - and up to a
distance of 15 pc from the shock front. The ionized medium is in the immediate
vicinity of the remnant, as evinced by the smooth brightening of both lines as
the adiabatic shock transition (defined by the X-ray perimeter) is crossed.
These lines are usually brighter around the Cygnus Loop than in the general
background in directions where the galactic latitude is above 5 degrees. There
is also marginal (but significant) evidence that the degree of ionization is
somewhat larger around the Cygnus Loop. We conclude that the energy necessary
to ionize this large bubble of gas could have been supplied by an O8 or O9 type
progenitor or the particles heated by the expanding shock front. The second
possibility, though highly atractive, would have to be assessed by extensive
modelling.Comment: 18 pages, 8 figures, ApJ 512 in pres
Release of extracellular membrane vesicles from microvilli of epithelial cells is enhanced by depleting membrane cholesterol
AbstractWe previously reported on the occurrence of prominin-1-carrying membrane vesicles that are released into body fluids from microvilli of epithelial cells. This release has been implicated in cell differentiation. Here we have characterized these vesicles released from the differentiated Caco-2 cells. We find that in these vesicles, prominin-1 directly interacts with membrane cholesterol and is associated with a membrane microdomain. The cholesterol depletion using methyl-ÎČ-cyclodextrin resulted in a marked increase in their release, and a dramatic change in the microvillar ultrastructure from a tubular shape to a âpearlingâ state, with multiple membrane constrictions, suggesting a role of membrane cholesterol in vesicle release from microvilli
DNAM-1 and PVR Regulate Monocyte Migration through Endothelial Junctions
DNAX accessory molecule 1 (DNAM-1; CD226) is a transmembrane glycoprotein involved in T cell and natural killer (NK) cell cytotoxicity. We demonstrated recently that DNAM-1 triggers NK cellâmediated killing of tumor cells upon engagement by its two ligands, poliovirus receptor (PVR; CD155) and Nectin-2 (CD112). In the present paper, we show that PVR and Nectin-2 are expressed at cell junctions on primary vascular endothelial cells. Moreover, the specific binding of a soluble DNAM-1âFc molecule was detected at endothelial junctions. This binding was almost completely abrogated by anti-PVR monoclonal antibodies (mAbs), but not modified by antiâNectin-2 mAbs, which demonstrates that PVR is the major DNAM-1 ligand on endothelial cells. Because DNAM-1 is highly expressed on leukocytes, we investigated the role of the DNAM-1âPVR interaction during the monocyte transendothelial migration process. In vitro, both antiâDNAM-1 and anti-PVR mAbs strongly blocked the transmigration of monocytes through the endothelium. Moreover, after antiâDNAM-1 or anti-PVR mAb treatment, monocytes were arrested at the apical surface of the endothelium over intercellular junctions, which strongly suggests that the DNAM-1âPVR interaction occurs during the diapedesis step. Altogether, our results demonstrate that DNAM-1 regulates monocyte extravasation via its interaction with PVR expressed at endothelial junctions on normal cells
SPICES: Spectro-Polarimetric Imaging and Characterization of Exoplanetary Systems
SPICES (Spectro-Polarimetric Imaging and Characterization of Exoplanetary
Systems) is a five-year M-class mission proposed to ESA Cosmic Vision. Its
purpose is to image and characterize long-period extrasolar planets and
circumstellar disks in the visible (450 - 900 nm) at a spectral resolution of
about 40 using both spectroscopy and polarimetry. By 2020/22, present and
near-term instruments will have found several tens of planets that SPICES will
be able to observe and study in detail. Equipped with a 1.5 m telescope, SPICES
can preferentially access exoplanets located at several AUs (0.5-10 AU) from
nearby stars (25 pc) with masses ranging from a few Jupiter masses to Super
Earths (2 Earth radii, 10 M) as well as circumstellar
disks as faint as a few times the zodiacal light in the Solar System
SPICES: Spectro-Polarimetric Imaging and Characterization of Exoplanetary Systems - From Planetary Disks To Nearby Super Earths
SPICES (Spectro-Polarimetric Imaging and Characterization of Exoplanetary Systems) is a five-year M-class mission proposed to ESA Cosmic Vision. Its purpose is to image and characterize long-period extrasolar planets and circumstellar disks in the visible (450-900 nm) at a spectral resolution of about 40 using both spectroscopy and polarimetry. By 2020/2022, present and near-term instruments will have found several tens of planets that SPICES will be able to observe and study in detail. Equipped with a 1.5 m telescope, SPICES can preferentially access exoplanets located at several AUs (0.5-10 AU) from nearby stars (less than 25 pc) with masses ranging from a few Jupiter masses to Super Earths (approximately 2 Earth radii, approximately 10 mass compared to Earth) as well as circumstellar disks as faint as a few times the zodiacal light in the Solar System
Masitinib (AB1010), a Potent and Selective Tyrosine Kinase Inhibitor Targeting KIT
International audienceBackground: The stem cell factor receptor, KIT, is a target for the treatment of cancer, mastocytosis, and inflammatory diseases. Here, we characterise the in vitro and in vivo profiles of masitinib (AB1010), a novel phenylaminothiazole-type tyrosine kinase inhibitor that targets KIT. Methodology/Principal Findings: In vitro, masitinib had greater activity and selectivity against KIT than imatinib, inhibiting recombinant human wild-type KIT with an half inhibitory concentration (IC50) of 200 ± 40 nM and blocking stem cell factor-induced proliferation and KIT tyrosine phosphorylation with an IC50 of 150 ± 80 nM in Ba/F3 cells expressing human or mouse wild-type KIT. Masitinib also potently inhibited recombinant PDGFR and the intracellular kinase Lyn, and to a lesser extent, fibroblast growth factor receptor 3. In contrast, masitinib demonstrated weak inhibition of ABL and c-Fms and was inactive against a variety of other tyrosine and serine/threonine kinases. This highly selective nature of masitinib suggests that it will exhibit a better safety profile than other tyrosine kinase inhibitors; indeed, masitinib-induced cardiotoxicity or genotoxicity has not been observed in animal studies. Molecular modelling and kinetic analysis suggest a different mode of binding than imatinib, and masitinib more strongly inhibited degranulation, cytokine production, and bone marrow mast cell migration than imatinib. Furthermore, masitinib potently inhibited human and murine KIT with activating mutations in the juxtamembrane domain. In vivo, masitinib blocked tumour growth in mice with subcutaneous grafts of Ba/F3 cells expressing a juxtamembrane KIT mutant. Conclusions: Masitinib is a potent and selective tyrosine kinase inhibitor targeting KIT that is active, orally bioavailable in vivo, and has low toxicit
Mutations in Eml1 lead to ectopic progenitors and neuronal heterotopia in mouse and human.
Neuronal migration disorders such as lissencephaly and subcortical band heterotopia are associated with epilepsy and intellectual disability. DCX, PAFAH1B1 and TUBA1A are mutated in these disorders; however, corresponding mouse mutants do not show heterotopic neurons in the neocortex. In contrast, spontaneously arisen HeCo mice display this phenotype, and our study revealed that misplaced apical progenitors contribute to heterotopia formation. While HeCo neurons migrated at the same speed as wild type, abnormally distributed dividing progenitors were found throughout the cortical wall from embryonic day 13. We identified Eml1, encoding a microtubule-associated protein, as the gene mutated in HeCo mice. Full-length transcripts were lacking as a result of a retrotransposon insertion in an intron. Eml1 knockdown mimicked the HeCo progenitor phenotype and reexpression rescued it. We further found EML1 to be mutated in ribbon-like heterotopia in humans. Our data link abnormal spindle orientations, ectopic progenitors and severe heterotopia in mouse and human
- âŠ